Antiretroviral treatment in HIV-1 infected pediatric patients: focus on efavirenz
{{output}}
Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI), used for the treatment of human immunodeficiency virus (HIV)-1 infection. Approved by the US Food and Drug Administration in 1998, its indication was recently extended to include children a... ...
